We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.6B
AUM Growth
+$301M
Cap. Flow
-$663M
Cap. Flow %
-1.81%
Top 10 Hldgs %
13.88%
Holding
773
New
94
Increased
191
Reduced
352
Closed
92

Sector Composition

Rank Sector Weight
1 Healthcare 14.93%
2 Financials 13.18%
3 Technology 12.48%
4 Industrials 10.21%
5 Consumer Discretionary 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGI
626
DELISTED
Renewable Energy Group, Inc.
REGI
$3.46M 0.01%
356,396
-343,604
-49% -$3.21M
GMS
627
DELISTED
GMS Inc
GMS
$3.4M 0.01%
+116,120
New +$2.83M
FSLR icon
628
First Solar
FSLR
$22.1B
$3.33M 0.01%
103,700
-1,500
-1% -$52.6K
AMTD
629
DELISTED
TD Ameritrade Holding Corp
AMTD
$3.27M 0.01%
+75,000
New +$2.91M
CX icon
630
Cemex
CX
$17.2B
$3.23M 0.01%
+418,809
New +$3.33M
CRIS icon
631
Curis
CRIS
$9.67M
$3.19M 0.01%
518
+300
+138% +$1.8M
NVET
632
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$2.97M 0.01%
795,000
ICUI icon
633
ICU Medical
ICUI
$4.21B
$2.95M 0.01%
+20,000
New +$2.89M
SNR
634
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$2.94M 0.01%
300,000
OKE icon
635
Oneok
OKE
$56.1B
$2.89M 0.01%
+50,283
New +$2.64M
WM icon
636
Waste Management
WM
$90.9B
$2.87M 0.01%
40,439
-498,282
-92% -$33.3M
RCKT icon
637
Rocket Pharmaceuticals
RCKT
$351M
$2.87M 0.01%
117,500
MTVA
638
MetaVia Inc
MTVA
$7.44M
$2.85M 0.01%
6
RARX
639
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.66M 0.01%
+175,000
New +$2.38M
NPKI
640
NPK International
NPKI
$1.05B
$2.63M 0.01%
+350,000
New +$2.54M
NRE
641
DELISTED
NorthStar Realty Europe Corp.
NRE
$2.6M 0.01%
207,251
-1,292,749
-86% -$14.2M
ATRA icon
642
Atara Biotherapeutics
ATRA
$73.6M
$2.54M 0.01%
+7,160
New +$3.03M
RXDX
643
DELISTED
Ignyta, Inc.
RXDX
$2.5M 0.01%
472,686
-202,314
-30% -$1.18M
COL
644
DELISTED
Rockwell Collins
COL
$2.41M 0.01%
25,965
-11,244
-30% -$991K
DXPE icon
645
DXP Enterprises
DXPE
$2.4B
$2.31M 0.01%
+66,370
New +$1.96M
ADAP
646
DELISTED
Adaptimmune Therapeutics
ADAP
$2.16M 0.01%
533,901
-623,148
-54% -$2.99M
ASIX icon
647
AdvanSix
ASIX
$555M
$2.05M 0.01%
+92,476
New +$1.66M
NWS icon
648
News Corp Class B
NWS
$17.2B
$2.04M 0.01%
172,565
+17,696
+11% +$225K
TPST icon
649
Tempest Therapeutics
TPST
$13.8M
$1.96M 0.01%
438
-160
-27% -$1.99M
GPOR
650
DELISTED
Gulfport Energy Corp.
GPOR
$1.84M 0.01%
85,000
-1,075,000
-93% -$27.6M

Similar funds

Adage Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Adage Capital Partners held 773 positions worth $36.6B, up 0.83% from $36.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Adage Capital Partners's Q4 2016 filing shows 94 new, 191 increased, 352 reduced and 92 closed positions. Its largest new stake was NXP Semiconductors: 960,000 shares worth $94.1M. The largest sale was LinkedIn Corporation, an estimated $159M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Adage Capital Partners's largest Q4 2016 buy was NXP Semiconductors: 960,000 shares worth $94.1M.
  • Adage Capital Partners added most to Wells Fargo in Q4 2016, an estimated $210M increase.
  • Adage Capital Partners's biggest Q4 2016 reduction was Honeywell, cutting an estimated $150M.
  • Adage Capital Partners fully exited LinkedIn Corporation in Q4 2016, selling an estimated $159M.
  • Adage Capital Partners's ten largest holdings make up 14% of its $36.6B portfolio in Q4 2016.
  • Adage Capital Partners opened 94 new positions and closed 92 in Q4 2016.
  • Adage Capital Partners's portfolio value rose 0.83% quarter-over-quarter to $36.6B.

Based on Adage Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.